Orthocell Limited (OCC.AX)
AUD 1.25
(-0.4%)
AUD 1.25
(-0.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -11.68 Million AUD | -17.69% |
| 2023 | -9.92 Million AUD | 12.71% |
| 2022 | -11.52 Million AUD | 0.51% |
| 2021 | -11.66 Million AUD | -21.99% |
| 2020 | -9.25 Million AUD | -10.98% |
| 2019 | -8.53 Million AUD | -5.86% |
| 2018 | -8.29 Million AUD | -30.28% |
| 2017 | -6.52 Million AUD | -14.51% |
| 2016 | -5.81 Million AUD | -5.84% |
| 2015 | -5.8 Million AUD | -84.56% |
| 2014 | -3.3 Million AUD | -106.36% |
| 2013 | -1.3 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -14.43% |
| 2024 Q2 | -5.7 Million AUD | 0.0% |
| 2024 Q4 | -5.39 Million AUD | 0.0% |
| 2023 FY | - AUD | 12.71% |
| 2023 Q2 | -5.11 Million AUD | 0.0% |
| 2023 Q4 | -4.67 Million AUD | 0.0% |
| 2022 Q2 | -4.49 Million AUD | 0.0% |
| 2022 Q4 | -6.68 Million AUD | 0.0% |
| 2022 FY | - AUD | 0.51% |
| 2021 FY | - AUD | -21.99% |
| 2021 Q4 | -4.43 Million AUD | 0.0% |
| 2021 Q2 | -6.79 Million AUD | 0.0% |
| 2020 FY | - AUD | -10.98% |
| 2020 Q4 | -4.3 Million AUD | 0.0% |
| 2020 Q2 | -4.89 Million AUD | 0.0% |
| 2019 FY | - AUD | -5.86% |
| 2019 Q4 | -4.46 Million AUD | 0.0% |
| 2019 Q2 | -3.83 Million AUD | 0.0% |
| 2018 Q2 | -3.1 Million AUD | 0.0% |
| 2018 FY | - AUD | -30.28% |
| 2018 Q4 | -4.73 Million AUD | 0.0% |
| 2017 FY | - AUD | -14.51% |
| 2017 Q2 | -2.8 Million AUD | 0.0% |
| 2017 Q4 | -3.2 Million AUD | 0.0% |
| 2016 Q2 | -2.34 Million AUD | 0.0% |
| 2016 Q4 | -2.91 Million AUD | 0.0% |
| 2016 FY | - AUD | -5.84% |
| 2015 Q2 | -2.79 Million AUD | 0.0% |
| 2015 Q4 | -2.16 Million AUD | 0.0% |
| 2015 FY | - AUD | -84.56% |
| 2014 FY | - AUD | -106.36% |
| 2014 Q4 | -2.36 Million AUD | 0.0% |
| 2014 Q2 | -324.95 Thousand AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q3 | - AUD | 100.0% |
| 2013 Q4 | -584.25 Thousand AUD | 0.0% |
| 2013 Q2 | -719.23 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 212.584% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -701.909% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 67.945% |
| Biome Australia Limited | -1.57 Million AUD | -640.131% |
| Patrys Limited | -3.49 Million AUD | -234.496% |
| Imugene Limited | -147.97 Million AUD | 92.106% |
| Noxopharm Limited | -5.94 Million AUD | -96.47% |
| PYC Therapeutics Limited | -38.11 Million AUD | 69.355% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -3.375% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -62.561% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -48.1% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -17.396% |
| CSL Limited | 4.73 Billion AUD | 100.247% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -32.242% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -292.644% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 122.523% |
| Starpharma Holdings Limited | -12.57 Million AUD | 7.123% |
| Nanollose Limited | -1.14 Million AUD | -917.607% |
| Memphasys Limited | -3.3 Million AUD | -253.147% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -1521.385% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -550.293% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -156.188% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 16.08% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -314.501% |
| Race Oncology Limited | -14.2 Million AUD | 17.758% |
| Nyrada Inc. | -4.59 Million AUD | -154.147% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 150.863% |
| Dimerix Limited | -24.95 Million AUD | 53.198% |
| PharmAust Limited | -9.45 Million AUD | -23.587% |
| Immutep Limited | -42.87 Million AUD | 72.756% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 73.837% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 40.316% |
| BTC Health Limited | 1.05 Million AUD | 1206.914% |
| Acrux Limited | -7.93 Million AUD | -47.284% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 105.862% |
| Biotron Limited | -5.04 Million AUD | -131.766% |
| Tissue Repair Ltd | -5.77 Million AUD | -102.271% |
| AdAlta Limited | -5.3 Million AUD | -120.286% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 74.257% |
| Hexima Limited | -995.54 Thousand AUD | -1073.341% |
| AnteoTech Limited | -11.57 Million AUD | -0.952% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 81.901% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 45.298% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -260.249% |
| Actinogen Medical Limited | -12.92 Million AUD | 9.597% |
| Immuron Limited | -6.19 Million AUD | -88.638% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -515.576% |